BGM Group Ltd. (BGM) vs LENZ Therapeutics, Inc. (LENZ)

A side-by-side comparison of BGM Group Ltd. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BGM vs LENZ

growth of $100 · dividends reinvested · last 2y
BGM -94.3% (-76.2%/yr)LENZ -85.1% (-61.3%/yr)LENZ compounded faster over this window
0100200300Start $10020252026$6$15
BGM LENZ

BGM vs LENZ: by the numbers

  • •LENZ is the larger company ($119M vs $112M market cap).
  • •Both run net losses; BGM's is the smaller (-52.59% vs -586.74% net margin).

Metrics side by side

Valuation

MetricBGMLENZ
P/S ratioN/A5.54
P/B ratio0.280.54

Profitability

MetricBGMLENZ
Gross margin12.79%90.14%
Operating margin-33.18%-477.46%
Net margin-52.59%-586.74%
ROE-5.10%-57.47%
ROIC-3.19%-61.84%

Growth (annualized)

MetricBGMLENZ
Revenue CAGR (5Y)-5.39%N/A
Total return CAGR (5Y)N/A-35.49%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.